SCHEMBL8480946

SCHEMBL8480946

CCOC(=O)C(=O)C(Cc1cc2c(cc1Cl)OCO2)C(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.41
NPC1 O15118 4/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2C9 P11712 1/20 0.37
HTT P42858 1/20 0.37
CTNNB1 P35222 1/20 0.37
WNT3A P56704 1/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP19A1 P11511 1/20 0.36
TSHR P16473 1/20 0.36
ELANE P08246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7473018 0.85 CTNNB1 (0.42) RAB9ANPC1SMN1; SMN2CTNNB1WNT3A
SCHEMBL8478679 0.85 RAB9A (0.41) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL8477041 0.85 RAB9A (0.42) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL6940934 0.79 CYP3A4 (0.42) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL6943904 0.79 CYP3A4 (0.44) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL10871043 0.76 CYP3A4 (0.46) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL3572819 0.73 KMT2A (0.49) RAB9ANPC1MAPTL3MBTL1CYP1A2
SCHEMBL7472228 0.71 CYP1A2 (0.38) CYP1A2CYP3A4CYP2D6CYP2C19CYP2C9
SCHEMBL7466139 0.70 NPC1 (0.47) RAB9ANPC1MAPTSMN1; SMN2CYP3A4
SCHEMBL8477323 0.69 SMN1; SMN2 (0.42) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5942622-A NOVEL COMPOUNDS FOR TREATING ILLNESS RESULTING FROM ABNORMAL STIMULATION OF ENDOTHELIAL RECEPTORS; FOR EXAMPLE: 4-((6-CHLORO-1,3-BENZODIOXOL-5-YL)METHYL)-1-(CYCLOHEXYLMETHYL) -3-(2-PYRIDINYL)-1H-PYRAZOLE-5-CARBOXYLATE HOECHST MARION ROUSSEL (FR) 1999-08-24 US disclosed